Ian Clark - Sabre Insurance Non-Executive Independent Director
| 18M Stock | EUR 1.70 0.07 4.29% |
Insider
Ian Clark is Non-Executive Independent Director of Sabre Insurance Group since 2014.
| Tenure | 10 years |
| Phone | 44 33 0024 4696 |
| Web | https://www.sabreplc.co.uk |
Ian Clark Latest Insider Activity
Tracking and analyzing the buying and selling activities of Ian Clark against Sabre Insurance stock is an integral part of due diligence when investing in Sabre Insurance. Ian Clark insider activity provides valuable insight into whether Sabre Insurance is net buyers or sellers over its current business cycle. Note, Sabre Insurance insiders must abide by specific rules, including filing SEC forms every time they buy or sell Sabre Insurance'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Ian Clark over six months ago Acquisition by Ian Clark of 15000 shares of Corvus Pharmaceuticals at 2.74 subject to Rule 16b-3 |
Sabre Insurance Management Efficiency
The company has return on total asset (ROA) of 0.0211 % which means that it generated a profit of $0.0211 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0651 %, meaning that it generated $0.0651 on every $100 dollars invested by stockholders. Sabre Insurance's management efficiency ratios could be used to measure how well Sabre Insurance manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 10 records | INSIDER Age | ||
| Masahiro Fukui | Sanyo Chemical Industries | N/A | |
| Takao Ando | Sanyo Chemical Industries | 70 | |
| Kinya Ito | Sanyo Chemical Industries | N/A | |
| Hiroyuki Susaki | Sanyo Chemical Industries | N/A | |
| Hiroyuki Tsuruta | Sanyo Chemical Industries | N/A | |
| Yuichi Fujii | Sanyo Chemical Industries | N/A | |
| Akinori Higuchi | Sanyo Chemical Industries | 64 | |
| Kohei Maeda | Sanyo Chemical Industries | 63 | |
| Hiroyuki Shimominami | Sanyo Chemical Industries | 63 | |
| Masahiro Harada | Sanyo Chemical Industries | N/A | |
Management Performance
| Return On Equity | 0.0651 | |||
| Return On Asset | 0.0211 |
Sabre Insurance Group Leadership Team
Elected by the shareholders, the Sabre Insurance's board of directors comprises two types of representatives: Sabre Insurance inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sabre. The board's role is to monitor Sabre Insurance's management team and ensure that shareholders' interests are well served. Sabre Insurance's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sabre Insurance's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Geoff Carter, Chief Executive Officer, Executive Director | ||
| James Ockenden, Chief Actuary | ||
| Geoffrey Carter, CEO Director | ||
| Ian Clark, Non-Executive Independent Director | ||
| Anneka Kingan, Chief Risk Officer, Company Secretary | ||
| Matt Wright, Chief Actuary | ||
| Trevor Webb, Claims Director | ||
| Andy Pomfret, Independent Non-Executive Chairman of the Board | ||
| Patrick Snowball, Non-Executive Chairman of the Board | ||
| Catherine Barton, Non-Executive Independent Director | ||
| Michael Koller, Non-Executive Director | ||
| Adam Westwood, Chief Financial Officer, Executive Director | ||
| Rebecca Shelley, Senior Non-Executive Independent Director |
Sabre Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sabre Insurance a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0651 | |||
| Return On Asset | 0.0211 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 271.5 M | |||
| Shares Outstanding | 250 M | |||
| Shares Owned By Insiders | 10.32 % | |||
| Shares Owned By Institutions | 85.08 % | |||
| Price To Earning | 12.32 X | |||
| Price To Book | 1.14 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Sabre Stock
Sabre Insurance financial ratios help investors to determine whether Sabre Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sabre with respect to the benefits of owning Sabre Insurance security.